Triple
T370478
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Cancer Immunology Research |
E8257
|
entity |
| Predicate | abbreviation |
P43
|
FINISHED |
| Object | Cancer Immunol Res |
E8257
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cancer Immunol Res | Statement: [Cancer Immunology Research, abbreviation, Cancer Immunol Res]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cancer Immunol Res Context triple: [Cancer Immunology Research, abbreviation, Cancer Immunol Res]
-
A.
Cancer Immunology Research
chosen
Cancer Immunology Research is a peer-reviewed scientific journal focusing on research at the intersection of immunology and cancer biology, including cancer immunotherapy and tumor-immune system interactions.
-
B.
Cancer Res
Cancer Res is a leading peer-reviewed scientific journal that publishes research on the molecular and cellular biology, genetics, and treatment of cancer.
-
C.
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics is a peer-reviewed scientific journal focusing on the discovery, development, and clinical evaluation of novel cancer therapeutics.
-
D.
Cancer Discovery
Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
-
E.
Clinical Cancer Research
Clinical Cancer Research is a peer-reviewed medical journal focusing on innovative clinical and translational research in oncology.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a2e7f2ec648190b42bc7db424f8109 |
completed | Feb. 28, 2026, 1:04 p.m. |
| NER | Named-entity recognition | batch_69a2ebff472881909fad81d597425ea6 |
completed | Feb. 28, 2026, 1:22 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a3ecac7e048190a76c02c738599c61 |
completed | March 1, 2026, 7:37 a.m. |
Created at: Feb. 28, 2026, 1:08 p.m.